(19)
(11) EP 3 777 937 A8

(12) CORRECTED EUROPEAN PATENT APPLICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 A1)

(48) Corrigendum issued on:
30.06.2021 Bulletin 2021/26

(43) Date of publication:
17.02.2021 Bulletin 2021/07

(21) Application number: 20177876.8

(22) Date of filing: 26.04.2011
(51) International Patent Classification (IPC): 
A61M 15/00(2006.01)
A61M 16/00(2006.01)
A61M 16/06(2006.01)
C01B 21/24(2006.01)
A61M 16/10(2006.01)
A62B 7/00(2006.01)
A61M 16/12(2006.01)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 26.04.2010 US 32801010 P

(62) Application number of the earlier application in accordance with Art. 76 EPC:
11775504.1 / 2563435

(71) Applicant: VERO Biotech LLC
Cocoa, FL 32926 (US)

(72) Inventors:
  • FINE, David H.
    Cocoa Beach, FL 32932 (US)
  • VASQUEZ, Gregory
    Cocoa Beach, FL 32922 (US)
  • JOHNSON, Bryan
    Orlando, FL 32833 (US)
  • DENTON, Ryan
    Titusville, FL 32780 (US)
  • GAMERO, Lucas G.
    Oviedo, FL 32765 (US)

(74) Representative: D Young & Co LLP 
120 Holborn
London EC1N 2DY
London EC1N 2DY (GB)

 
Remarks:
This application was filed on 02.06.2020 as a divisional application to the application mentioned under INID code 62.
Remarks:
Claims filed after the date of filing of the application / after the date of receipt of the divisional application (Rule 68(4) EPC)
 


(54) DELIVERY OF ULTRA PURE NITRIC OXIDE (NO)


(57) A system for delivering a therapeutic amount of nitric oxide can include reservoir assembly, a gas supply (1035), and a delivery conduit including a first cartridge (1060) wherein the first cartridge (1060) can include a surface-activated material saturated with aqueous solution of a reducing agent.